Enliven Takes Precision Oncology Ambitions Public In Merger With Imara

 
• By Joseph Haas
  
Enliven Imara merger
Enliven will reverse merge with troubled Imara in an all-stock deal • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business